Synthesis of Furans by RCM/Deprotonation/Phosphorylation
1
(500 mg, 2.7 mmol). H NMR spectroscopy of the crude reaction
Dimethyl 1-[(Diphenoxyphosphoryl)oxy]-4-phenethyl-7-oxabicyclo-
[2.2.1]hepta-2,5-diene-2,3-dicarboxylate (7a): By starting from puri-
fied 3ad (968 mg, 2.3 mmol), the title compound 7a (1.14 g,
2.0 mmol, 88%) was obtained by applying the general procedure
mixture indicated complete conversion into 3ad. For this particular
example, analytically pure 3ad (1.02 g, 2.4 mmol, 89%) was ob-
tained by column chromatography on silica with only a slightly
reduced yield. 1H NMR (300 MHz, CDCl3): δ = 7.42–7.33 (5 H, after purification by column chromatography on silica gel with a
1
Aryl), 7.31–7.14 (10 H, Aryl), 5.88 (d, J = 3.2 Hz, 1 H, 9-H), 5.63 mixture of hexane/tert-butyl methyl ether (3:1) as eluent. H NMR
(dd, J = 3.1, 2.3 Hz, 1 H, 8-H), 2.94–2.80 (4 H, 5-H, 6-H) ppm. (300 MHz, CDCl3): δ = 7.39–7.16 (16 H, Aryl, 9-H), 6.98 (dd, J =
13C NMR (75 MHz, CDCl3): δ = 150.2, 148.1, 148.0, 140.7, 129.8, 5.2, 1.0 Hz, 1 H, 8-H), 3.78 (s, 3 H, 14-H/16-H), 3.69 (s, 3 H, 16-
128.3, 128.2, 126.0, 125.8, 120.0, 106.5, 90.2, 34.0, 29.7 ppm. 31P
H/14-H), 2.69 (dd, J = 8.3, 8.1 Hz, 2 H, 5-H), 2.64–2.42 (2 H, 6-
NMR (121.5 MHz, CDCl3): δ = –17.7 ppm. HRMS (EI): calcd. for H) ppm. 13C NMR (75 MHz, CDCl3): δ = 163.2, 162.4, 153.1,
C24H21O5P [M]+ 420.1127; found 420.1113. C24H21O5P (420.39): 151.3, 150.3, 146.6, 142.5, 141.0, 129.6, 128.4, 126.1, 125.5, 120.3,
calcd. C 68.6, H 5.0; found C 68.4, H 4.9.
111.8, 91.4, 52.4, 52.2, 31.0, 30.9 ppm. 31P NMR (121.5 MHz,
CDCl ): δ = –16.1 ppm. IR (neat): ν = 1718, 1589, 1488, 1282,
˜
3
5-Pentylfuran-2-yl Diphenyl Phosphate (3cd): By applying the gene-
ral procedure, the title compound was obtained from 5c (82 mg,
0.5 mmol). 1H NMR spectroscopy of the crude reaction mixture
indicated complete conversion into 3cd. 1H NMR (300 MHz,
CDCl3): δ = 7.45–7.18 (10 H, Aryl), 5.88 (d, J = 3.1 Hz, 1 H, 8-
H), 5.62 (dd, J = 3.1, 2.4 Hz, 1 H, 7-H), 2.51 (t, J = 7.5 Hz, 2 H,
5-H), 1.63–1.52 (2 H, 4-H), 1.40–1.25 (4 H, 2-H, 3-H), 0.95–0.85
(3 H, 1-H) ppm. 13C NMR (75 MHz, CDCl3): δ = 150.2, 149.8,
149.4, 147.9, 130.1, 129.9, 126.4, 125.9, 120.4, 120.1, 105.8, 90.1,
31.2, 27.8, 27.4, 22.3, 13.9 ppm. 31P NMR (121.5 MHz, CDCl3): δ
= –17.7 ppm.
1178, 1009, 957, 844, 754, 688 cm–1. HRMS (EI): calcd. for
C30H27O9P [M]+ 562.1387; found 562.1393. C30H27O9P (562.50):
calcd. C 64.1, H 4.8; found C 63.9, H 4.8.
Dimethyl
1-[(Diphenoxyphosphoryl)oxy]-4-pentyl-7-oxabicyclo-
[2.2.1]hepta-2,5-diene-2,3-dicarboxylate (7c): The title compound
was obtained from crude 3cd [synthesized from 5c (82 mg,
0.5 mmol) as described above] by applying the general procedure.
After purification by column chromatography on silica with hex-
ane/tert-butyl methyl ether mixtures (3:1 to 1:1) as eluent, 7c
(183 mg, 0.4 mmol, 82% based on 5c) was isolated. 1H NMR
(300 MHz, CDCl3): δ = 7.38–7.16 (11 H, Aryl, 8-H), 6.99 (d, J =
5.2 Hz, 1 H, 7-H), 3.79 (s, 3 H, 13-H/15-H), 3.66 (s, 3 H, 15-H/13-
H), 2.25–2.08 (2 H, 5-H), 1.47–1.20 (6 H, 2-H, 3-H, 4-H), 0.92–
0.84 (3 H, 1-H) ppm. 13C NMR (75 MHz, CDCl3): δ = 163.3,
162.3, 153.9, 150.7, 150.3, 146.8, 142.1, 129.7, 125.4, 120.3, 111.7,
92.0, 52.4, 52.2, 31.8, 28.8, 24.5, 22.4, 13.9 ppm. 31P NMR
(R)-5-(2,2-Dimethyl-1,3-dioxolan-4-yl)furan-2-yl Diphenyl Phos-
phate (3ed): By applying the general procedure, the title compound
was obtained from 5e (98 mg, 0.5 mmol). 1H NMR spectroscopy
of the crude reaction mixture indicated complete conversion into
3ed. 1H NMR (300 MHz, CDCl3): δ = 7.45–7.19 (10 H, Aryl), 6.29
(d, J = 3.3 Hz, 1 H, 8-H), 5.72 (dd, J = 3.3, 2.2 Hz, 1 H, 7-H), 4.96
(dd, J = 7.1, 6.9 Hz, 1 H, 5-H), 4.18 (dd, J = 8.4, 6.5 Hz, 1 H, 4-
Ha), 4.01 (dd, J = 8.3, 7.5 Hz, 1 H, 4-Hb), 1.46 (s, 3 H, 1-H/2-H),
1.43 (s, 3 H, 2-H/1-H) ppm. 13C NMR (75 MHz, CDCl3): δ =
150.2, 149.9, 149.7, 144.7, 130.1, 129.9, 126.4, 125.9, 120.4, 120.1,
110.1, 90.7, 71.1, 67.6, 26.3, 25.9 ppm. 31P NMR (121.5 MHz,
CDCl3): δ = –18.1 ppm.
(121.5 MHz, CDCl ): δ = –16.1 ppm. IR (neat): ν = 1717, 1589,
˜
3
1488, 1435, 1282, 1179, 1162, 1009, 956, 883, 754, 687 cm–1. HRMS
(EI): calcd. for C27H29O9P [M]+ 528.1544; found 528.1555. HRMS
(ESI): calcd. for C27H29O9PNa [M + Na]+ 551.1447; found
551.0958. C27H29O9P (528.49): calcd. C 61.4, H 5.5; found C 61.1,
H 5.6.
Dimethyl 1-[(R)-2,2-Dimethyl-1,3-dioxolan-4-yl]-4-[(diphenoxyphos-
phoryl)oxy]-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate
(7e): The title compound was obtained from crude 3ed [synthesized
from 5e (98 mg, 0.5 mmol) as described above] by applying the ge-
neral procedure. After purification by column chromatography on
silica with hexane/tert-butyl methyl ether mixtures (2:1 to 1:1) as
eluent, 7e (104 mg, 0.2 mmol, 45% based on 5e) was isolated as a
1:1 mixture of diastereomers. Partial separation of the dia-
stereomers was achieved by careful chromatography. Analytical
data of the less polar diastereomer: [α]2D1 = –14.8 (c = 6, CH2Cl2).
1H NMR (300 MHz, CDCl3): δ = 7.38–7.16 (12 H, Aryl, 7-H, 8-
H), 4.93 (t, J = 6.2 Hz, 1 H, 4-H), 4.13 (dd, J = 8.6, 6.9 Hz, 1 H,
3-Ha), 3.97 (dd, J = 8.6, 5.7 Hz, 1 H, 3-Hb), 3.78 (s, 3 H, 13-H/
15-H), 3.67 (s, 3 H, 15-H/13-H), 1.39 (br. s, 3 H, 1-H/2-H], 1.38
(br. s, 3 H, 2-H/1-H) ppm. 13C NMR (75 MHz, CDCl3): δ = 162.9,
161.8, 152.5, 150.2, 144.8, 142.3, 142.2, 129.7, 125.6, 120.4, 111.8,
110.5, 91.2, 72.4, 65.9, 52.6, 52.3, 25.9, 25.3 ppm. 31P NMR
Diphenyl 5-Phenylfuran-2-yl Phosphate (3fd): By applying the gene-
ral procedure, the title compound was obtained from 5f (85 mg,
0.5 mmol). 1H NMR spectroscopy of the crude reaction mixture
indicated complete conversion into 3fd. 1H NMR (300 MHz,
CDCl3): δ = 7.56–7.51 (2 H, Aryl), 7.46–7.21 (13 H, Aryl), 6.56 (d,
J = 3.4 Hz, 1 H, 7-H), 5.86 (dd, J = 3.4, 2.2 Hz, 1 H, 6-H) ppm.
13C NMR (75 MHz, CDCl3): δ = 150.2, 149.8, 149.3, 146.8, 130.1,
129.9, 129.7, 128.6, 127.3, 126.4, 125.9, 120.4, 120.1, 106.0,
92.1 ppm. 31P NMR (121.5 MHz, CDCl3): δ = –17.9 ppm.
5-[(Benzyloxy)methyl]furan-2-yl Diphenyl Phosphate (3gd): By ap-
plying the general procedure, the title compound was obtained
1
from 5g (108 mg, 0.5 mmol). H NMR spectroscopy of the crude
reaction mixture indicated complete conversion into 3gd. 1H NMR
(300 MHz, CDCl3): δ = 7.38–7.10 (15 H, Aryl), 6.19 (d, J = 3.3 Hz,
1 H, 9-H), 5.67 (dd, J = 3.3, 2.2 Hz, 1 H, 8-H), 4.46 (s, 2 H, 5-H),
4.31 (s, 2 H, 6-H) ppm. 13C NMR (75 MHz, CDCl3): δ = 150.2,
149.7, 144.7, 131.7, 130.1, 129.9, 128.4, 127.9, 127.7, 126.4, 125.9,
120.4, 120.1, 111.1, 90.7, 71.8, 63.7 ppm. 31P NMR (121.5 MHz,
CDCl3): δ = –17.9 ppm.
(121.5 MHz, CDCl ): δ = –16.2 ppm. IR (neat): ν = 1720, 1589,
˜
3
1488, 1436, 1285, 1257, 1182, 1162, 1010, 961, 843, 770, 689 cm–1.
HRMS (EI): calcd. for C27H27O11PNa [M]+ 558.1286; found
General Procedure for the Diels–Alder Reactions of Furanyl Phos- 558.1278. C27H27O11P (558.47): calcd. C 58.1, H 4.9; found C 57.9,
1
phates 3#d: The appropriate crude or purified furanyl phosphate
3#d was dissolved in xylene (2 mL/mmol). DMAD (3.0 equiv.) was
added, and the reaction mixture was heated at 135 °C. After com-
plete consumption of the starting material, the solvent was re-
moved in vacuo. The residue was purified by column chromatog-
raphy on silica gel with a mixture of hexane and tert-butyl methyl
ether as eluent.
H 4.8. Analytical data for the more polar diastereomer of 7e: H
NMR (300 MHz, CDCl3): δ = 7.38–7.15 (10 H, Aryl, 8-H), 6.98
(br. d, J = 5.3 Hz, 1 H, 7-H), 4.94 (dd, J = 6.4, 6.4 Hz, 1 H, 5-H),
4.11 (dd, J = 8.6, 6.9 Hz, 1 H, 4-Ha), 3.96 (dd, J = 8.6, 6.0 Hz, 1
H, 4-Hb), 3.81 (s, 3 H, 13-H/15-H), 3.67 (s, 3 H, 15-H/13-H), 1.37
(br. s, 3 H, 1-H/2-H), 1.36 (br. s, 3 H, 2-H/1-H) ppm. 13C NMR
(75 MHz, CDCl3): δ = 163.2, 161.9, 152.5, 150.3, 149.9, 144.8,
Eur. J. Org. Chem. 2011, 7140–7147
© 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
7145